Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.

× No keyword cloud information.

23 in total

1. Behavioral correlates of dopaminergic supersensitivity.

Authors: S D Iversen; I Creese
Journal: Adv Neurol Date: 1975

2. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.

Authors: J R Walters; R H Roth; G K Aghajanian
Journal: J Pharmacol Exp Ther Date: 1973-09 Impact factor: 4.030

3. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors: R Laverty; K M Taylor
Journal: Anal Biochem Date: 1968-02 Impact factor: 3.365

4. Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate.

Authors: P F Spano; A Tagliamonte; P Tagliamonte; G L Gessa
Journal: J Neurochem Date: 1971-10 Impact factor: 5.372

5. Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.

Authors: M C Nowycky; R H Roth
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-11 Impact factor: 3.000

6. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors: R H Roth; L C Murrin; J R Walters
Journal: Eur J Pharmacol Date: 1976-03 Impact factor: 4.432

7. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.

Authors: G Gianutsos; J E Thornburg; K E Moore
Journal: Psychopharmacology (Berl) Date: 1976-11-24 Impact factor: 4.530

8. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors: W Kehr; A Carlsson; M Lindqvist
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1972 Impact factor: 3.000

9. Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.

Authors: G Gianutsos; K E Moore
Journal: J Pharmacol Exp Ther Date: 1978-12 Impact factor: 4.030

10. The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors: G F Murphy; D Robinson; D F Sharman
Journal: Br J Pharmacol Date: 1969-05 Impact factor: 8.739

3 in total

1. Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Authors: Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris
Journal: Am J Drug Alcohol Abuse Date: 2017-06-29 Impact factor: 3.829

2. Evidence for down-regulation of GABA receptors following long-term gamma-butyrolactone.

Authors: G Gianutsos; P D Suzdak
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1984-11 Impact factor: 3.000

3. Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.

Authors: O Giorgi; M C Rubio
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1981-12 Impact factor: 3.000

3 in total